{
  "id": 15579673,
  "title": "Warren Buffett's Bluntest Warning Yet -- and 3 Stocks Built to Survive It",
  "url": "https://urgent.news/2026/10/19/warren-buffetts-bluntest-warning-yet-and-3-stocks-built-to-survive-it",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-19T08:10:00.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/10/19/warren-buffetts-bluntest-warning-yet-and-3-stocks/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "Warren Buffett issued his strongest warning to Wall Street during an interview with CNBC. He remarked that people are currently in the riskiest \"gambling mood\" yet. The billionaire investor recommended that investors focus on long-term strategies instead of short-term options. Despite his retirement, Buffett remains active in investment discussions as chairman emeritus of Berkshire Hathaway. He identified three stocks as being particularly resilient during market turmoil. Vertex Pharmaceuticals, a leader in cystic fibrosis treatment, stands to benefit from its strong intellectual property and expanding business. Eli Lilly, with its weight loss drug Mounjaro, is dominating a high-growth market projected to reach nearly $100 billion by the end of the decade. Lastly, AbbVie, maker of the best-selling drug Humira, remains a Dividend King with a stable portfolio across various treatment areas.",
  "summary": "Buffett has warned about \"gambling\" in the market.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Warren Buffett's Bluntest Warning Yet -- and 3 Stocks Built to Survive It",
        "url": "https://urgent.news/2026/10/19/warren-buffetts-bluntest-warning-yet-and-3-stocks-built-to-survive-it-15588100",
        "published": "2026-10-19T08:30:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}